Skip to main content
JUDGES SCIENTIFIC PLC logo

JUDGES SCIENTIFIC PLC — Investor Relations & Filings

Ticker · JDG ISIN · GB0032398678 LEI · 2138004EXWWPTW1JOL31 IL Manufacturing
Filings indexed 617 across all filing types
Latest filing 2023-02-01 Declaration of Voting R…
Country GB United Kingdom
Listing IL JDG

About JUDGES SCIENTIFIC PLC

https://www.judges.uk.com/

Judges Scientific PLC is a group focused on acquiring and developing a portfolio of scientific instrument businesses. The group's strategy combines corporate expansion through the acquisition of established, niche companies with fostering organic growth within its subsidiaries. These subsidiaries design and produce a wide range of specialized scientific instruments that are sold worldwide. The portfolio serves diverse markets, including higher education institutions, scientific research communities, manufacturers, and regulatory authorities. Key application areas for its instruments include materials science, life sciences (such as electrophysiology and microscopy), geosciences (geological core, soil, and rock analysis), fiber optics, and fire testing technology.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement identified by the 'RNS Number' header and the presence of the 'RNS' footer, indicating it is a regulatory news service release from the London Stock Exchange. The content explicitly states the 'Total Voting Rights' as of a specific date (1 February 2023) and confirms the total issued share capital. This type of notification regarding the total number of voting rights, which shareholders use for disclosure calculations, is a specific regulatory update. While it relates to share capital, it is not a formal share issue announcement (SHA) or a transaction in own shares (POS). It is a mandatory disclosure related to the company's structure for transparency rules. Given the options, this fits best as a general Regulatory Filing (RNS) or potentially a Share Issue/Capital Change (SHA) if the increase was due to a recent issue. However, since it is primarily a notification of the *current* total voting rights denominator, and it is a brief regulatory update, RNS is the most appropriate general classification for mandatory, non-financial report disclosures that don't fit elsewhere. Since the document is very short and is a direct regulatory notification, RNS is the best fit.
2023-02-01 English
Grant of Options
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 5527N' and contains standard boilerplate language from RNS, the news service of the London Stock Exchange. The content announces the 'Grant of Options' to Executive Directors, detailing the number of options, exercise price, and vesting conditions. This type of announcement, which details insider transactions (specifically option grants to directors), falls under the category of Director's Dealing (DIRS) or potentially a general regulatory filing. However, since it specifically details transactions/grants involving directors, DIRS is a strong candidate. Upon reviewing the definitions, DIRS is for 'Report of personal share transactions by company directors and executives (insider trades)'. Option grants are a form of executive compensation/insider transaction. Given the context of an RNS release detailing director-specific share awards, DIRS is the most precise fit among the specific options, although it is not a typical 'dealing' report, it relates directly to executive equity. If DIRS is too narrow, RNS (General Regulatory Filings) is the fallback. Since it is a specific announcement about executive equity awards, DIRS is chosen over the general RNS category. The document is short and is an announcement, not a comprehensive report.
2023-01-23 English
Full Year Trading Statement and Notice of Results
Earnings Release Classification · 98% confidence The document is identified by the RNS Number header and contains a 'Full Year Trading Statement and Notice of Final Results' for the period ended 31 December 2022. It provides key trading highlights (organic order intake, revenue, acquisition contribution) and explicitly states the 'Notice of Final Results' date (22 March 2023). This structure—a trading update combined with a notice about the upcoming full results announcement—is characteristic of an Earnings Release (ER) or a preliminary trading update, rather than the full Annual Report (10-K) or a comprehensive Interim Report (IR). Since it is an initial announcement of performance for the period, ER is the most appropriate fit, although it also contains a notice element. Given the content focuses on preliminary performance figures, ER is selected over RPA, which is usually just an announcement *about* a report release. FY 2022
2023-01-19 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Director/PDMR Shareholding' and details transactions (purchases) of ordinary shares by key personnel (CEO, Group Finance Director, COO) of Judges Scientific plc. This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing. The presence of 'RNS Number' and the closing statement referencing RNS and the London Stock Exchange confirms it is a regulatory disclosure, but the specific content points overwhelmingly to Director's Dealing (DIRS).
2023-01-09 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement disseminated via RNS (Regulatory News Service) from Judges Scientific PLC, dated January 3, 2023. The core content explicitly states the 'Total Voting Rights' and confirms the total issued share capital (6,369,746 Ordinary shares). This information is crucial for shareholders to calculate their notifiable interests under Disclosure and Transparency Rules. This type of mandatory disclosure regarding the total number of shares and voting rights is a standard regulatory filing. Since it is a general regulatory announcement that doesn't fit perfectly into specific categories like DIV, SHA, or DIRS, and is distributed via RNS, the most appropriate classification is the general regulatory filing category, RNS, although it touches upon share capital changes (SHA). Given the context of an RNS distribution and the nature of the disclosure (total voting rights denominator), RNS is the best fit as a general regulatory update.
2023-01-03 English
Block listing Interim Review
Report Publication Announcement Classification · 99% confidence The document is titled 'Blocklisting Return' and contains specific tabular data detailing the movement of shares under 'Judges' Approved and Unapproved Share Option Schemes' over a defined period (10 June 2022 to 21 December 2022). It explicitly mentions compliance with 'Schedule 6 of the AIM Rules for Companies'. This structure is characteristic of a regulatory filing related to share capital management, specifically a blocklisting return required by the London Stock Exchange's AIM market rules. While it is a regulatory filing, the specific nature points towards a filing related to capital structure or share issuance reporting, but given the options, it is a specific regulatory announcement. Since it is not a standard 10-K, ER, or IR, and it deals with share schemes and listing rules, it fits best under the general 'Regulatory Filings' (RNS) category as a specific compliance document, or potentially 'Share Issue/Capital Change' (SHA). However, 'Blocklisting Return' is a very specific regulatory disclosure, often categorized broadly. Given the presence of 'RNS Number' and the overall format typical of LSE announcements, RNS is the most appropriate general regulatory bucket if a more specific one like SHA (which usually covers new issues/splits) doesn't perfectly capture a blocklisting return. Since the document is a formal, structured regulatory disclosure provided via RNS, I will classify it as RNS, which serves as the fallback for specific regulatory notices not covered elsewhere.
2022-12-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.